Author

Mitali Paryani

Institutions: Nirma University, Swarrnim Startup and Innovation University

Observed institutions: Nirma University, Swarrnim Startup and Innovation University

ORCID: 0000-0002-5610-6811

Observed ORCID: 0000-0002-5610-6811

OpenAlex ID: A5090913772

Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs

2020 · Namdev Dhas, Ritu Kudarha, et al. · Journal of Controlled Release · 80

Therapeutic Strategies for Idiopathic Pulmonary Fibrosis – Thriving Present and Promising Tomorrow

2024 · Nikita Gupta, Mitali Paryani, et al. · The Journal of Clinical Pharmacology · 10

Lowering LDL cholesterol by PCSK9 inhibition: a new era of gene silencing, RNA, and alternative therapies

2025 · Mitali Paryani, Nikita Gupta, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 4

Biodegradable Polymers in Tissue Engineering and Regenerative Medicine

2024 · Atul Garkal, Priyanka Bangar, et al. · 3

Improving pharmacokinetics and pharmacodynamics of berberine hydrochloride using solid dispersion: A therapeutic approach to hyperlipidemia

2026 · Mitali Paryani, Nikita Gupta, et al. · Drying Technology

Improving pharmacokinetics and pharmacodynamics of berberine hydrochloride using solid dispersion: A therapeutic approach to hyperlipidemia

2026 · Mitali Paryani, Nikita Gupta, et al. · Figshare

Inhalable quercetin dihydrate nanosuspension mitigates silica-induced pulmonary fibrosis in rats

2026 · Nikita Gupta, Mitali Paryani, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology

Works count: 7

Citation count: 97

H-index: 3

I10-index: 2